Bryan F. Shaw, Ph.D.

Bryan F. Shaw, Ph.D., professor of chemistry and biochemistry at Baylor University, has made worldwide news by making science education accessible to students with blindness or low vision (BLV). His innovative work, featured on the cover of the prestigious journal Science Advances, introduced a first-of-its-kind tactile learning device that transforms scientific data and images into functional, detailed formats for BLV students. This advancement opens the door for equitable learning opportunities in STEM fields, ensuring that complex scientific concepts can be understood through touch rather than sight. 

The study, Universal pictures: A lithophane codex helps teenagers with blindness visualize nanoscopic systems, details Dr. Shaw’s creative use of the ancient art form lithophane – a thin, translucent engraving or embossing of an image – to convert textbook images into tactile codices. Shaw has demonstrated the real-world impact of this technology through hands-on learning experiences with students from the Texas School for the Blind and Visually Impaired. His dedication to inclusivity and innovation in science education exemplifies why he is deserving of the Newsmaker of the Year award for 2023-2024.

Shaw’s research has been featured prominently in several top-level news outlets, including NBC News, Science Friday, Chemistry World, Texas Standard, Popular Science and Texas Monthly.

ABOUT BRYAN F. SHAW, PH.D.

Bryan F. Shaw, Ph.D., is a professor of chemistry and biochemistry at Baylor University, whose research is a mix of bio-inorganic chemistry, protein biophysics, medicinal chemistry and proteomics. His lab, The Shaw Research Group, leads pioneering initiatives for students who are blind or visually impaired, including the use of 3D printing to create atomically accurate protein models from X-ray crystal structures. These tactile models allow students to experience the dynamic nature of protein structure and allostery through touch. In addition, his team has developed tools to help parents detect retinoblastoma, a rare childhood eye cancer, using consumer digital photography – potentially saving lives through earlier diagnosis.

Recognized internationally for his commitment to inclusivity and innovation, Dr. Shaw exemplifies how cutting-edge research can transform both science and society.